Atlas Trials

Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet Autoantibodies

Clinical trial NCT02387164 · TERMINATED

Trial details

NCT number
NCT02387164
Sponsor
Lund University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1Prediabetic State
Start date
2015-03-09
Primary completion
2019-10-07
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.